Transesophageal Echocardiography
9
1
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (9)
Manual- VS Auto-Strain
Superior Vena Cava Collapsibility Index for Predicting Fluid Responsiveness During High-risk Non-cardiac Surgery
Perioperative Rescue Transesophageal Echocardiography in Intensive and Critical Status
Using TEE to Evaluate the Effect of Levosimendan on Patients With ARDS Associated With RVD During MV
Rate of Left Ventricular Systolic Function's Recuperation After Cardiac Surgery With Extracorporeal Circulation.
Respiratory Variations of the Diameter of Superior Vena Cava for Predicting Fluid Responsiveness After Cardiac Surgery
Left Atrial Thrombus on Transesophageal Echocardiography
Estimation of Pulmonary Arterial Pressure With Transesophageal Echocardiography: a Pilot Study
The Effect of Sedation During Transesophageal Echocardiography on Heart Rate Variability